Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry.
Publication/Presentation Date
1-1-2019
Abstract
Upper airway stimulation (UAS) has been shown to reduce severity of obstructive sleep apnoea. The aim of this study was to identify predictors of UAS therapy response in an international multicentre registry.Patients who underwent UAS implantation in the United States and Germany were enrolled in an observational registry. Data collected included patient characteristics, apnoea/hypopnoea index (AHI), Epworth sleepiness scale (ESS), objective adherence, adverse events and patient satisfaction measures.
Volume
53
Issue
1
ISSN
1399-3003
Published In/Presented At
Heiser, C., Steffen, A., Boon, M., Hofauer, B., Doghramji, K., Maurer, J. T., Sommer, J. U., Soose, R., Strollo, P. J., Jr, Schwab, R., Thaler, E., Withrow, K., Kominsky, A., Larsen, C., Kezirian, E. J., Hsia, J., Chia, S., Harwick, J., Strohl, K., Mehra, R., … ADHERE registry investigators (2019). Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry. The European respiratory journal, 53(1), 1801405. https://doi.org/10.1183/13993003.01405-2018
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
30487205
Department(s)
Administration and Leadership
Document Type
Article